Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aveanna Healthcare Holdings, Inc.AVAH · Entity 4246 | Director · See Remarks | February 14, 2022 | August 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aveanna Healthcare Holdings, Inc.
Report date February 14, 2022 · Filed August 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 1,915,125 |
Reported balance
After 2022-02-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-02-14 · Grant · Acquired 268,509 · Balance 1,915,125 F1: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting. F2: Includes 2,482 shares acquired under the issuer's Employee Stock Purchase Plan on January 4, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.
F2: Includes 2,482 shares acquired under the issuer's Employee Stock Purchase Plan on January 4, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2022 Filed May 20, 2022 17:32 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | PurchaseCommon Stock, par value $0.01 per share | 36,000 | $2.90 | $104,544.00 |
DisclosureSEC source: 0000899243-22-019087 · doc4.xml · nonDerivative · entry 1 Strange Tony · CIK 0001354350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680,134 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.85 to $2.97, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. ("Aveanna"), any security holder of Aveanna, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 14, 2022 Filed Aug 5, 2022 17:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 268,509 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-027843 · doc4.xml · nonDerivative · entry 1 Strange Tony · CIK 0001354350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,915,125 F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting. F2 · balance_after: Includes 2,482 shares acquired under the issuer's Employee Stock Purchase Plan on January 4, 2022. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 17:56 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | PurchaseCommon Stock, par value $0.01 per share | 15,000 | $6.48 | $97,200.00 |
DisclosureSEC source: 0000899243-21-048831 · doc4.xml · nonDerivative · entry 1 Strange Tony · CIK 0001354350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,644,134 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.